These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10547616)

  • 1. Flow cytometric chemosensitivity analysis of blasts from patients with acute myeloblastic leukemia and myelodysplastic syndromes: the use of 7AAD with antibodies to CD45 or CD34.
    Pallis M; Syan J; Russell NH
    Cytometry; 1999 Dec; 37(4):308-13. PubMed ID: 10547616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method comparison study of flow cytometry and cytomorphology to determine the percentages of blasts in patients with acute leukemia after induction and consolidation chemotherapy.
    Wongprajun S; Auewarakul CU
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S157-64. PubMed ID: 20364570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.
    Feller N; Kelder A; Westra G; Ossenkoppele GJ; Schuurhuis GJ
    Cytometry B Clin Cytom; 2008 Jan; 74(1):9-16. PubMed ID: 18061946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples.
    Garrido SM; Willman C; Appelbaum FR; Banker DE
    Cytometry; 2000 Apr; 42(2):83-94. PubMed ID: 10797445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes.
    Satoh C; Dan K; Yamashita T; Jo R; Tamura H; Ogata K
    Leuk Res; 2008 May; 32(5):699-707. PubMed ID: 17936901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.
    Yang GS; Wang C; Minkin S; Minden MD; McCulloch EA
    J Cell Physiol; 1991 Jul; 148(1):60-7. PubMed ID: 1860896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
    Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
    Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic monitoring of BAY 43-9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells.
    Tong FK; Chow S; Hedley D
    Cytometry B Clin Cytom; 2006 May; 70(3):107-14. PubMed ID: 16498671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large populations of non-clonogenic early apoptotic CD34-positive cells are present in frozen-thawed peripheral blood stem cell transplants.
    Schuurhuis GJ; Muijen MM; Oberink JW; de Boer F; Ossenkoppele GJ; Broxterman HJ
    Bone Marrow Transplant; 2001 Mar; 27(5):487-98. PubMed ID: 11313682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB; Pardo ML; Pavlovsky MA; Fernandez I; Corrado CS; Giere I; Sapia S; Pavlovsky S
    Cytometry B Clin Cytom; 2006 Mar; 70(2):63-70. PubMed ID: 16470534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering.
    Keeney M; Chin-Yee I; Weir K; Popma J; Nayar R; Sutherland DR
    Cytometry; 1998 Apr; 34(2):61-70. PubMed ID: 9579602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemistry and flow cytometry evaluation of human megakaryocytes in fresh samples and cultures of CD34+ cells.
    Qiao X; Loudovaris M; Unverzagt K; Walker DE; Smith SL; Martinson J; Schilling M; Lee W; Williams SF; Van Epps DE; Cohen I; Bender JG
    Cytometry; 1996 Mar; 23(3):250-9. PubMed ID: 8974870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry assessment of apoptotic CD34+ cells by annexin V labeling may improve prediction of cord blood potency for engraftment.
    Duggleby RC; Querol S; Davy RC; Fry LJ; Gibson DA; Horton RB; Mahmood SN; Gomez SG; Madrigal JA
    Transfusion; 2012 Mar; 52(3):549-59. PubMed ID: 21883264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DRAQ5-based DNA content analysis of hematolymphoid cell subpopulations discriminated by surface antigens and light scatter properties.
    Yuan CM; Douglas-Nikitin VK; Ahrens KP; Luchetta GR; Braylan RC; Yang L
    Cytometry B Clin Cytom; 2004 Mar; 58(1):47-52. PubMed ID: 14994375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined flow cytometric assessment of CD45, HLA-DR, CD34, and CD117 expression is a useful approach for reliable quantification of blast cells in myelodysplastic syndromes.
    Sandes AF; Kerbauy DM; Matarraz S; Chauffaille Mde L; López A; Orfao A; Yamamoto M
    Cytometry B Clin Cytom; 2013 May; 84(3):157-66. PubMed ID: 23475532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.
    Hans CP; Finn WG; Singleton TP; Schnitzer B; Ross CW
    Am J Clin Pathol; 2002 Feb; 117(2):301-5. PubMed ID: 11863227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accurate assessment of cell count and viability with a flow cytometer.
    Shenkin M; Babu R; Maiese R
    Cytometry B Clin Cytom; 2007 Sep; 72(5):427-32. PubMed ID: 17266154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.